Codi QR

Tau biology, biomarkers, and therapeutics

Abstract As Alzheimer's disease (AD) research advances, tau has emerged as both a critical biomarker and a promising therapeutic target, central to understanding disease mechanisms, tracking progression, and guiding treatment development. The Fall 2024 Alzheimer's Association Research Roundtable con...

Descripció completa

Guardat en:
Autors principals: Bess Frost, Hartmuth Kolb, Alicia Algeciras‐Schimnich, Tobey J. Betthauser, Sarah DeVos, Rebecca M. Edelmayer, Fiona Elwood, Adam S. Fleisher, David Henley, Kanta Horie, Bradley Hyman, William Charles Kreisl, Luka Kulic, Antoine Leuzy, Jose‐Alberto Palma, Sophie Parmentier‐Batteur, Maria‐Magdalena Patru, Gil D. Rabinovici, Larisa Reyderman, Reisa A. Sperling, Serge Van Der Geyten, Kristin R. Wildsmith, Simin Mahinrad, Maria C. Carrillo, Christopher J. Weber
Format: Artigo
Idioma:Inglês
Publicat: Wiley 2025-10-01
Col·lecció:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Matèries:
Alzheimer's disease staging
Alzheimer's disease treatments
amyloid
AUC
biomarker
clinical trials
Accés en línia:https://doi.org/10.1002/trc2.70165
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars